The Transcriptional Coactivator Peroxisome Proliferator–Activated Receptor (PPAR)γ Coactivator-1α and the Nuclear Receptor PPARα Control the Expression of Glycerol Kinase and Metabolism Genes Independently of PPARγ Activation in Human White Adipocytes
Open accessAbstract
OBJECTIVE—The purpose of this work was to determine the pattern of genes regulated by peroxisome proliferator–activated receptor (PPAR) γ coactivator 1α (PGC-1α) in human adipocytes and the involvement of PPARα and PPARγ in PGC-1α transcriptional action. RESEARCH DESIGN AND METHODS—Primary cultures of human adipocytes were transduced with a PGC-1α adenovirus and treated with PPARγ and PPARα agonists. Variation in gene expression was assessed using pangenomic microarrays and quantitative RT-PCR. To investigate glycerol kinase (GyK), a target of PGC-1α, we measured enzymatic activity and glycerol incorporation into triglycerides. In vivo studies were performed on wild-type and PPARα−/− mice. The GyK promoter was studied using chromatin immunoprecipitation and promoter reporter gene assays. RESULTS—Among the large number of genes regulated by PGC-1α independently of PPARγ, new targets involved in metabolism included the gene encoding GyK. The induction of GyK by PGC-1α was observed at the levels of mRNA, enzymatic activity, and glycerol incorporation into triglycerides. PPARα was also upregulated by PGC-1α. Its activation led to an increase in GyK expression and activity. PPARα was shown to bind and activate the GyK promoter. Experiments in mice confirmed the role of PGC-1α and PPARα in the regulation of GyK in vivo. CONCLUSIONS—This work uncovers novel pathways regulated by PGC-1α and reveals that PPARα controls gene expression in human white adipocytes. The induction of GyK by PGC-1α and PPARα may promote a futile cycle of triglyceride hydrolysis and fatty acid reesterification.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The triglyceride/fatty acid cycle is present in human white adipocytes in vitro after treatment with the specific PPARα agonist, GW7647.
“Recent evidence has shown that this cycle is also present in human white adipocytes in vitro after treatment with the specific PPARα agonist, GW7647 29.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 38 · Cited by 90
- Authors
- Mazzucotelli, A., Viguerie, N., Tiraby, C., Annicotte, J.-S., Mairal, A., Klimcakova, E., Lepin, E., Delmar, P., Dejean, S., Tavernier, G., Lefort, C., Hidalgo, J., Pineau, T., Fajas, L., Clément, K., & Langin, D.
- Affiliations
- Université Toulouse III - Paul Sabatier (FR)
- INSERM U834, Metabolism and Cancer Laboratory, Montpellier, F-34090, France
- Institut National de la Santé et de la Recherche Médicale (INSERM) U858, Obesity Research Laboratory, Toulouse, F-31432, France
- École Centrale Paris (FR)
- Centre National de la Recherche Scientifique, Statistics and Probality Laboratory, Paul Sabatier University, Toulouse, F-31400, France
- Universitat Autònoma de Barcelona (ES)
- Institut National de la Recherche Agronomique (FR)
- INSERM U872, Human Research Center on Nutrition, Hôtel Dieu, Paris, F-75181, France
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2007-10-01
- Volume
- 56
- Issue
- 10
- Pages
- 2467-2475
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2163047733
- Cited by
- 90
- References
- 38
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 5 · 2019: 2 · 2018: 10 · 2017: 5 · 2016: 5 · 2015: 3 · 2014: 4 · 2013: 6 · 2012: 3
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- European Commission (LSHM‐CT‐2005‐018734, SAF2005-00671, LSHMCT-2004-005272)
- Institut National de la Santé et de la Recherche Médicale
- Institut National de la Recherche Agronomique
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- PGC-1α, PPARα, PPARγ, glycerol kinase, white adipocytes, lipolysis, fatty acid re-esterification, gene expression regulation, PPARα knockout mice, promoter binding, adipocyte metabolism
- MeSH terms
- Gene Expression Regulation, Glycerol Kinase, Humans, Gene Expression Regulation, Enzymologic, Adipocytes, PPAR alpha, PPAR gamma, Intracellular Signaling Peptides and Proteins, Nuclear Receptor Coactivators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review